三星医疗将回购注销41,800股限制性股票

Core Viewpoint - Ningbo Samsung Medical Electric Co., Ltd. announced the repurchase and cancellation of 41,800 restricted stocks due to the departure of five incentive targets, which does not meet the incentive conditions [1] Group 1 - The company will complete the cancellation of the stocks by September 12, 2025 [1] - Following the cancellation, the total share capital will decrease from 1,405,251,200 shares to 1,405,209,400 shares [1] - The company confirmed that the decision-making process for the repurchase and cancellation is compliant with regulations and does not harm the rights of relevant parties [1]